Ethyl 5-acetoxy-6-bromo-2-(bromomethyl)-1-methyl-1H-indole-3-carboxylate, 95.0%, 5g

Ethyl 3-(1-methyl-2-(((4-(N-((pentyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity), 97%, 50mg

(4-Amino-phenyl)-(3-methyl-piperidin-1-yl)-methanone, 95.0%, 5g

3-BENZYLCYCLOBUTANONE, 95.0%, 250mg

Sodium 4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoate, 98%, 1g

Salicylic acid benzyl ester, min. 99%, 100 ml, glass packaging

(R)-3-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester, 100mg

(3-BROMO-1-METHYLPROPYL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

5-Bromo-2-methoxy-4-methylaniline, 97%, 250mg

Button cannulas, straight, 3.2 mm, 80 mm 6 pcs

(1S,3R)-3-((tert-Butoxycarbonyl)amino)-2,2-dimethylcyclobutanecarboxylic acid, 97%, 100mg

Benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate, 97.0%, 5g

tert-Butyl 2-oxo-2,3-dihydro-1H-spiro[benzo[e][1,4]oxazepine-5,4'-piperidine]-1'-carboxylate, 95+%, 250mg